Asthmapolis, the developer of an FDA-cleared inhaler sensor and application, has received another investment from the California Health Care Foundation's CHCF Innovation Fund that brings total funding from the group to more than $1 million. Asthmapolis plans to use the investment to pursue regulatory clearance in other countries, create new sensors to support a wide variety of medications and ensure patients with asthma, regardless of their socioeconomic status, can access its products.

Full Story:

Related Summaries